Faes Farma, S.A. (LON:0K9H)
4.579
-0.061 (-1.31%)
At close: Nov 14, 2025
Faes Farma Revenue
Faes Farma had revenue of 146.61M EUR in the quarter ending September 30, 2025, with 22.94% growth. This brings the company's revenue in the last twelve months to 571.12M, up 13.31% year-over-year. In the year 2024, Faes Farma had annual revenue of 510.04M with 7.81% growth.
Revenue (ttm)
571.12M EUR
Revenue Growth
+13.31%
P/S Ratio
2.55
Revenue / Employee
321.76K EUR
Employees
1,775
Market Cap
1.27B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
| Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
| Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
| Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
| Dec 31, 2020 | 411.49M | 28.30M | 7.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |